Serum interleukin 1β and sP-selectin as biomarkers of inflammation and thrombosis, could they be predictors of disease severity in COVID 19 Egyptian patients? (a cross-sectional study)

BACKGROUND: Thromboembolism was a chief cause of mortality in 70% of patients with COVID-19. Our objective was to see if serum interleukins 1 beta (IL-1β) and soluble platelets selectin (sP-selectin) could serve as novel markers of thromboembolism in COVID-19 patients. METHODS: This cross sectional...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd El-Ghani, Sara El-Sayed, Hamed, Reham Mohammad Raafat, Eid, Ragaey Ahmad, Ibrahim, Ahmed Yassin Mohammed, Abdel-Hamid, Hoda M., Abdelrahman, Walaa, Ibrahim, Raghda Ebaid, Abdel-Aziz, Manar Mahmoud, Mohamed, Marwa Salah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754776/
https://www.ncbi.nlm.nih.gov/pubmed/36522776
http://dx.doi.org/10.1186/s12959-022-00428-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754776/
https://www.ncbi.nlm.nih.gov/pubmed/36522776
http://dx.doi.org/10.1186/s12959-022-00428-5

Ejemplares similares